On July 11, 2024, Adam Levy, CFO of Mineralys Therapeutics Inc (NASDAQ:MLYS), sold 10,757 shares at $13.14 each, now holding 247,611 shares. The company focuses on precision medicine for cardiovascular and kidney diseases.
Read MoreDid you find this insightful?
Bad
Just Okay
Amazing